156 related articles for article (PubMed ID: 10522573)
1. Ganciclovir resistance in a heart transplant recipient infected by cytomegalovirus.
Manso JV; Lambert JL; Oña M; de la Iglesia JL; Iglesias J
Int J Cardiol; 1999 Sep; 71(1):97-8. PubMed ID: 10522573
[No Abstract] [Full Text] [Related]
2. Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
Chong PP; Teiber D; Prokesch BC; Arasaratnam RJ; Peltz M; Drazner MH; Garg S
Transpl Infect Dis; 2018 Oct; 20(5):e12965. PubMed ID: 29989279
[TBL] [Abstract][Full Text] [Related]
3. Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
Drobyski WR; Knox KK; Carrigan DR; Ash RC
Transplantation; 1991 Jul; 52(1):155-7. PubMed ID: 1650043
[No Abstract] [Full Text] [Related]
4. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
Mylonakis E; Kallas WM; Fishman JA
Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
[TBL] [Abstract][Full Text] [Related]
5. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
Limaye AP; Corey L; Koelle DM; Davis CL; Boeckh M
Lancet; 2000 Aug; 356(9230):645-9. PubMed ID: 10968438
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.
Julin JE; van Burik JH; Krivit W; Webb C; Holman CJ; Clark HB; Balfour HH
Transpl Infect Dis; 2002 Dec; 4(4):201-6. PubMed ID: 12535263
[TBL] [Abstract][Full Text] [Related]
7. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
Gilbert C; LeBlanc MH; Boivin G
Herpes; 2001 Nov; 8(3):80-2. PubMed ID: 11867025
[TBL] [Abstract][Full Text] [Related]
8. Ganciclovir resistance: a matter of time and titre.
Drew WL
Lancet; 2000 Aug; 356(9230):609-10. PubMed ID: 10968428
[No Abstract] [Full Text] [Related]
9. UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.
Gregg K; Hakki M; Kaul DR
Transpl Infect Dis; 2014 Apr; 16(2):320-3. PubMed ID: 24621186
[TBL] [Abstract][Full Text] [Related]
10. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively.
Baldanti F; Sarasini A; Silini E; Barbi M; Lazzarin A; Biron KK; Gerna G
Scand J Infect Dis Suppl; 1995; 99():103-4. PubMed ID: 8668930
[TBL] [Abstract][Full Text] [Related]
11. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.
Rosen HR; Benner KG; Flora KD; Rabkin JM; Orloff SL; Olyaei A; Chou S
Transplantation; 1997 Feb; 63(3):476-8. PubMed ID: 9039944
[No Abstract] [Full Text] [Related]
12. Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 12 Suppl 1():S1-22. PubMed ID: 8680897
[No Abstract] [Full Text] [Related]
13. CMV resistance: "more complicated than we thought".
Mascolini M
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):37-9. PubMed ID: 11363529
[TBL] [Abstract][Full Text] [Related]
14. Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.
Deback C; Burrel S; Varnous S; Carcelain G; Conan F; Aït-Arkoub Z; Autran B; Gandjbakhch I; Agut H; Boutolleau D
Antivir Ther; 2015; 20(2):249-54. PubMed ID: 25219330
[TBL] [Abstract][Full Text] [Related]
15. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
[TBL] [Abstract][Full Text] [Related]
16. Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
Goldsmith PM; Husain MM; Carmichael A; Zhang H; Middleton SJ
Transplantation; 2012 Apr; 93(7):e30-2. PubMed ID: 22450598
[No Abstract] [Full Text] [Related]
17. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
Chou S; Marousek G; Guentzel S; Follansbee SE; Poscher ME; Lalezari JP; Miner RC; Drew WL
J Infect Dis; 1997 Sep; 176(3):786-9. PubMed ID: 9291334
[TBL] [Abstract][Full Text] [Related]
18. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.
Erice A; Gil-Roda C; Pérez JL; Balfour HH; Sannerud KJ; Hanson MN; Boivin G; Chou S
J Infect Dis; 1997 May; 175(5):1087-92. PubMed ID: 9129070
[TBL] [Abstract][Full Text] [Related]
19. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]